Institutional Ownership Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO). We have compiled data on the 232 institutions that hold shares in the stock, with a total of 58.1 Million shares, which have been reported (via 13F filing form) to have a value of $3.34 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Farallon Capital Management LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
5,660,866
shares
|
$335 Million
1.26% of portfolio
|
Q3 2024
Added 0.11%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
5,545,982
shares
|
$328 Million
0.0% of portfolio
|
Q3 2024
Added 0.9%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,859,002
shares
|
$287 Million
0.0% of portfolio
|
Q2 2024
Added 4.31%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Nov 14, 2024 Q3 2024 |
3,735,915
shares
|
$221 Million
2.8% of portfolio
|
Q3 2024
Reduced 3.7%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,832,512
shares
|
$167 Million
0.01% of portfolio
|
Q3 2024
Added 1.99%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,331,433
shares
|
$138 Million
0.0% of portfolio
|
Q3 2024
Added 10.24%
|
|
|
Armistice Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
2,207,070
shares
|
$130 Million
1.63% of portfolio
|
Q3 2024
Added 6.15%
|
|
|
Erste Asset Management Gmb H
Vienna, C4 |
Nov 14, 2024 Q3 2024 |
2,184,900
shares
|
$129 Million
1.16% of portfolio
|
Q3 2022
Reduced 22.46%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
1,712,990
shares
|
$101 Million
0.01% of portfolio
|
Q3 2024
Reduced 3.56%
|
|
|
Macquarie Group LTD
Australia, C3 |
Nov 14, 2024 Q3 2024 |
1,690,801
shares
|
$99.9 Million
0.08% of portfolio
|
Q3 2024
Reduced 2.25%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
1,562,183
shares
|
$92.3 Million
0.02% of portfolio
|
Q3 2024
Reduced 28.87%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,357,531
shares
|
$80.2 Million
0.0% of portfolio
|
Q3 2024
Added 0.45%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
1,263,285
shares
|
$74.7 Million
0.07% of portfolio
|
Q3 2024
Added 11.43%
|
|
|
Bvf Inc
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,190,107
shares
|
$70.3 Million
1.68% of portfolio
|
Q2 2024
New holding
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
1,044,154
shares
|
$61.7 Million
2.5% of portfolio
|
Q3 2024
Added 19.75%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
1,002,036
shares
|
$59.2 Million
0.27% of portfolio
|
Q3 2024
New holding
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Nov 08, 2024 Q3 2024 |
907,044
shares
|
$53.6 Million
0.1% of portfolio
|
Q3 2024
Reduced 0.45%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Nov 14, 2024 Q3 2024 |
882,731
shares
|
$52.2 Million
0.56% of portfolio
|
Q3 2024
Reduced 13.4%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
882,402
shares
|
$52.1 Million
0.03% of portfolio
|
Q2 2023
Added 26.77%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2024 Q3 2024 |
855,328
shares
|
$50.5 Million
0.02% of portfolio
|
Q3 2024
Added 20.48%
|
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
760,000
shares
|
$44.9 Million
2.56% of portfolio
|
Q3 2024
New holding
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
699,389
shares
|
$41.3 Million
1.06% of portfolio
|
Q3 2024
Reduced 33.03%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
669,615
shares
|
$39.6 Million
0.01% of portfolio
|
Q3 2024
Added 1.11%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 07, 2024 Q3 2024 |
630,946
shares
|
$37.3 Million
0.24% of portfolio
|
Q3 2024
Added 6.03%
|
|
|
Loomis Sayles & CO L P
|
Nov 13, 2024 Q3 2024 |
612,366
shares
|
$36.2 Million
0.04% of portfolio
|
Q3 2024
Added 36.43%
|